| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Epilepsy | 2,172 | 284 | |
| Bipolar disorder | 1,937 | 249 | |
| Bipolar I disorder | 359 | 39 | |
| Bipolar II disorder | 332 | 42 | |
| Schizoaffective disorder | 276 | 24 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Weight gain | 155 | |
| Hair loss | 49 | |
| Fatigue | 42 | |
| Drowsiness | 26 | |
| Tremor in hands | 24 | |
| Nausea | 20 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 190 | |
| Moderate | 209 | |
| Mild | 198 | |
| None | 206 |
Member evaluations
neuroplasticity
evaluated on Jul 07, 2011
- Perceived effectiveness for epilepsy: Slight
- Side effects: Moderate
ArbonneDrew
evaluated on May 02, 2011
- Perceived effectiveness for epilepsy: Major
- Side effects: Severe
seasterday
evaluated on Nov 15, 2010
- Perceived effectiveness for epilepsy: Major
- Side effects: Severe